AIDS‐associated Cryptococcus neoformans and Penicillium marneffei coinfection: a therapeutic dilemma in resource‐limited settings

Clin Infect Dis. 2010 Nov 1;51(9):e65-8. doi: 10.1086/656685.

Abstract

AIDS‐associated Cryptococcus neoformans and Penicillium marneffei coinfection has not been adequately studied and poses unique therapeutic challenges in resource‐limited settings. Itraconazole poorly penetrates the central nervous system, whereas fluconazole has poor activity against P. marneffei. We prospectively report management of 1 patient and retrospectively review 7 coinfection cases from Vietnam.

Publication types

  • Case Reports
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • AIDS-Related Opportunistic Infections / diagnosis*
  • AIDS-Related Opportunistic Infections / drug therapy
  • AIDS-Related Opportunistic Infections / microbiology
  • Adult
  • Antifungal Agents / pharmacokinetics*
  • Antifungal Agents / therapeutic use*
  • Cryptococcus neoformans / drug effects
  • Cryptococcus neoformans / isolation & purification*
  • Developing Countries
  • Diagnosis, Differential
  • Fluconazole / pharmacokinetics
  • Fluconazole / therapeutic use
  • Humans
  • Itraconazole / pharmacokinetics
  • Itraconazole / therapeutic use
  • Male
  • Mycoses / diagnosis*
  • Mycoses / drug therapy*
  • Mycoses / microbiology
  • Penicillium / drug effects
  • Penicillium / isolation & purification*
  • Prospective Studies
  • Retrospective Studies
  • Vietnam

Substances

  • Antifungal Agents
  • Itraconazole
  • Fluconazole